EnLyte PD Gummy

EnLyte PD Gummy is a chewable medical food designed for children 2–12 years of age and formulated for the dietary management of pediatric patients with distinctive nutritional requirements related to brain chemistry, attention, and emotional regulation. It is intended for use under medical supervision as part of an individualized pediatric care plan.

EnLyte PD Gummy contains natural, clinically studied ingredients that support methylation, a critical biochemical process involved in the production and regulation of key neurotransmitters. Proper methylation supports balanced levels of serotonin, dopamine, and norepinephrine, which play essential roles in attention, mood regulation, motivation, and emotional stability during childhood development.

In addition to supporting neurotransmitter-related pathways, EnLyte PD Gummy is formulated to support broader cellular and metabolic processes involved in healthy brain development and function. The formulation provides essential B-vitamin coenzymes, mineral cofactors, and omega fatty acids required by the central nervous system for optimal methylation, monoamine production, membrane integrity, and antioxidant support.

EnLyte PD Gummy was evaluated in a recent open-label, preliminary clinical trial involving children with ADHD between the ages of 2 and 12. In this study, children receiving EnLyte PD Gummy demonstrated improvements on standardized behavioral rating scales over a 90-day period, with no discontinuations due to side effects. All study completers exhibited some degree of benefit, and the formulation was reported to be well tolerated, including in very young children.

The study population included children with genetic variants associated with altered nutrient metabolism, including polymorphisms affecting methylation and monoamine-related pathways. EnLyte PD Gummy was designed to provide bioavailable nutrient forms intended to help meet these genetically influenced nutritional requirements, which may not be adequately addressed by modification of the normal diet alone.

EnLyte PD Gummy is intended to be incorporated into a comprehensive pediatric care plan for children receiving ongoing medical supervision.

Dosing: Ages 2–8: One (1) gummy in the morning, with or without food, for children who cannot swallow or EnLyte, an easy-to-swallow gelcap with no age restriction for older children.

Dosing: Ages 9–12: Two (2) gummies in the morning, with or without food, for children who cannot swallow or EnLyte, an easy-to-swallow gelcap with no age restriction for older children.

Learn more